Elanco Animal Health Incorporated (ELAN)

13,53 +0,06 (+0,45%) Börsenschluss: 04:00PM EDT

Elanco Animal Health Incorporated

2500 Innovation Way
Greenfield, IN 46140
United States
877 352 6261
https://www.elanco.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 9.300

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Jeffrey N. Simmons	President, CEO & Director	2,46M	N/A	1967
Mr. Todd S. Young J.D.	Executive VP & CFO	1,11M	N/A	1972
Dr. Ramiro Martin Cabral	Executive Vice President of Elanco International	950,74k	N/A	1972
Dr. Ellen de Brabander Ph.D.	Executive Vice President of Innovation, Regulatory & Business Development	1,14M	N/A	1963
Mr. Timothy J. Bettington	Executive Vice President of Corporate Strategy & Market Development	1,19M	N/A	1974
Mr. James M. Meer	Senior VP & Chief Accounting Officer	N/A	N/A	1970
Mr. Chris Keeley	Senior VP & Chief Information Officer	N/A	N/A	N/A
Mr. David S. Kinard	Executive Vice President of Human Resources, Corporate Communications & Administration	722,58k	N/A	1967
Katy Grissom	Head of Investor Relations	N/A	N/A	N/A
Ms. Shiv O'Neill	Executive Vice President, General Counsel & Corporate Secretary	N/A	N/A	1974

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Corporate Governance

Elanco Animal Health Incorporateds ISS Governance QualityScore, Stand 1. Mai 2024, lautet 7. Die grundlegenden Scores sind Audit: 8, Vorstand: 8, Shareholderrechte: 7, Kompensation: 5.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.